Pharmesis International Ltd. | |
Stock Exchange | Singapore Exchange |
EPS |
SGD0.01 |
Market Cap |
SGD2.78 M |
Shares Outstanding |
23 M |
Public Float |
- |
Address |
No. 8 Yingbin Road Chengdu Sichuan 611331 China |
Employees | - |
Website | http://www.pharmesis.com |
Updated | 07/08/2019 |
Pharmesis International Ltd. Is an investment holding company, which engages in the research, development, production, sale, and marketing of medicine and medicine formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates through the following segments: Western Drugs, Traditional Chinese Medicine (TCM) Formulated Drugs, and Distribution. The Western Drugs segment involves in the chemically formulated drugs and is marketed under the Kinna brand. |